Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Submitted by
admin
on June 5, 2014 - 12:04pm
Source:
Yahoo/Benzinga
News Tags:
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
Headline:
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Do Not Allow Advertisers to Use My Personal information
